MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis

The development of vascular system depends on the coordinated activity of a number of distinct families of molecules including growth factors and their receptors, cell adhesion molecules, extracellular matrix (ECM) molecules, and proteolytic enzymes. Matrix metalloproteases (MMPs) are a family of ECM degrading enzymes required for both physiological and pathological angiogenesis. Increasing evidence, point to a direct role of membrane type-MMPs (MT-MMPs) in vascular system stabilization, maturation, and leakage. Our understanding of the nature of MT-MMP interaction with extracellular and cell surface molecules and their multiple roles in vessel walls and perivascular stroma may provide new insights into mechanisms underlying vascular cell–ECM interactions and cell fate decisions in pathological conditions. Regulation of vascular leakage by MT-MMP interactions with the ECM could also lead to novel targeting opportunities for drug delivery in tumor. This review will shed lights on the emerging roles of MT1-MMP and MT4-MMP in vascular system alterations associated with cancer progression.

[1]  Asif Ahmed,et al.  VEGF Induces Tie2 Shedding via a Phosphoinositide 3-Kinase/Akt–Dependent Pathway to Modulate Tie2 Signaling , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Kenji Nakamura,et al.  Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells , 2007, Journal of Cell Science.

[3]  Amber N. Stratman,et al.  Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. , 2009, Blood.

[4]  Hyun-Jai Cho,et al.  Cytokines and Matrix Metalloproteinases Progenitor Cells and Late Outgrowth Endothelial Cells: the Role of Angiogenic Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Ou , 2022 .

[5]  Y. Sato Activation of latent TGF-beta at the vascular wall--roles of endothelial cells and mural pericytes or smooth muscle cells. , 1995, Journal of atherosclerosis and thrombosis.

[6]  P. Iversen,et al.  Interstitial fluid: the overlooked component of the tumor microenvironment? , 2010, Fibrogenesis & tissue repair.

[7]  Lynda F. Bonewald,et al.  Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts , 2002, The Journal of Biological Chemistry.

[8]  D. McDonald,et al.  Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. , 2003, The American journal of pathology.

[9]  D. Azar,et al.  MT1-MMP-Mediated Cleavage of Decorin in Corneal Angiogenesis , 2009, Journal of Vascular Research.

[10]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[11]  Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. , 2006, Diabetes.

[12]  J. Foidart,et al.  Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases* , 2004, Journal of Biological Chemistry.

[13]  Asif Ahmed,et al.  VEGF Induces Tie 2 Shedding via a Phosphoinositide 3-Kinase / Akt – Dependent Pathway to Modulate Tie 2 Signaling , 2007 .

[14]  O. Féron Targeting the tumor vascular compartment to improve conventional cancer therapy. , 2004, Trends in pharmacological sciences.

[15]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[16]  J. Rundhaug,et al.  Matrix metalloproteinases and angiogenesis , 2005, Journal of cellular and molecular medicine.

[17]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[18]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[19]  Brian Seed,et al.  Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation , 2003, Nature Medicine.

[20]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[21]  A. Raza,et al.  Pericytes and vessel maturation during tumor angiogenesis and metastasis , 2010, American journal of hematology.

[22]  R. Iozzo,et al.  BMP-1/Tolloid-like Metalloproteases Process Endorepellin, the Angiostatic C-terminal Fragment of Perlecan* , 2005, Journal of Biological Chemistry.

[23]  M. Swartz,et al.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. , 2006, Microvascular research.

[24]  I. Bièche,et al.  Thrombospondin-1 Is a Plasmatic Marker of Peripheral Arterial Disease That Modulates Endothelial Progenitor Cell Angiogenic Properties , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Foidart,et al.  Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[26]  R. W. Rauser,et al.  Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Holger Gerhardt,et al.  Pericytes limit tumor cell metastasis. , 2006, The Journal of clinical investigation.

[28]  A. Redig,et al.  Rho-ROCK-Myosin Signaling Meditates Membrane Type 1 Matrix Metalloproteinase-induced Cellular Aggregation of Keratinocytes* , 2010, The Journal of Biological Chemistry.

[29]  K. Sekiguchi,et al.  Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin–integrin interactions using recombinant α3β1, α6β1, α7β1 and α6β4 integrins , 2006 .

[30]  Carine Munaut,et al.  Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. , 2006, Cancer research.

[31]  D. Edwards,et al.  Metalloproteinases and their inhibitors in angiogenesis , 2003, Expert Reviews in Molecular Medicine.

[32]  S. Hibino,et al.  Identification of an Active Site on the Laminin α5 Chain Globular Domain That Binds to CD44 and Inhibits Malignancy , 2004, Cancer Research.

[33]  P. Courtoy,et al.  Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. , 2006, European journal of cancer.

[34]  W. English,et al.  MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src , 2010, Journal of Cell Science.

[35]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[36]  A. Davidoff,et al.  Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. , 2002, Blood.

[37]  Michael D Feldman,et al.  Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. , 2003, The American journal of pathology.

[38]  A. Yayon,et al.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.

[39]  R. Iozzo,et al.  Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the α2β1-integrin receptor , 2007 .

[40]  Gabriele Bergers,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during , 2000 .

[41]  P. Iversen,et al.  The Role of the Extracellular Matrix in Tissue Distribution of Macromolecules in Normal and Pathological Tissues: Potential Therapeutic Consequences , 2008, Microcirculation.

[42]  R. Iozzo,et al.  Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the alpha2beta1-integrin receptor. , 2007, Blood.

[43]  Jingsong Xu,et al.  Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo , 2001, The Journal of cell biology.

[44]  L. Liotta,et al.  Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events , 1990, The Journal of cell biology.

[45]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[46]  G. Ahn,et al.  Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. , 2008, Cancer cell.

[47]  B. Hudson,et al.  MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. , 2009, Developmental cell.

[48]  H. Kleinman,et al.  Identification of redundant angiogenic sites in laminin α1 and γ1 chains , 2003 .

[49]  Holger Gerhardt,et al.  Pericytes: gatekeepers in tumour cell metastasis? , 2008, Journal of Molecular Medicine.

[50]  S Eguchi,et al.  Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.

[51]  A. Noël,et al.  Matrix metalloproteinases at cancer tumor-host interface. , 2008, Seminars in cell & developmental biology.

[52]  Bonnie F. Sloane,et al.  Proteases, extracellular matrix, and cancer: a workshop of the path B study section. , 2004, The American journal of pathology.

[53]  D. Pode,et al.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. , 1999, The Journal of clinical investigation.

[54]  K. Sekiguchi,et al.  Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[55]  M. Detmar,et al.  The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. , 2002, The American journal of pathology.

[56]  S. Paku Current concepts of tumor-induced angiogenesis , 2008, Pathology & Oncology Research.

[57]  R. Fridman,et al.  Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration. , 2010, Cancer research.

[58]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[59]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[60]  S. Krane,et al.  Stromal regulation of vessel stability by MMP14 and TGFβ , 2010, Disease Models & Mechanisms.

[61]  L. Coussens,et al.  Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[62]  H. Kleinman,et al.  Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro , 1989, Cell.

[63]  G. Davis,et al.  Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression , 2008, Current opinion in hematology.

[64]  I. Fidler,et al.  Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.

[65]  Ronald T Raines,et al.  Collagen structure and stability. , 2009, Annual review of biochemistry.

[66]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[67]  H. Kleinman,et al.  Identification of laminin alpha1 and beta1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  D. Gingras,et al.  Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase* , 2004, Journal of Biological Chemistry.

[69]  H. Augustin,et al.  Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.

[70]  C. Gilles,et al.  Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[71]  Hiroshi Sato,et al.  MT1-MMP promotes cell growth and ERK activation through c-Src and paxillin in three-dimensional collagen matrix. , 2010, Biochemical and biophysical research communications.

[72]  L. Devy,et al.  MTI-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression , 2002 .

[73]  Alex Y Strongin,et al.  Simultaneous visualization of protumorigenic Src and MT1-MMP activities with fluorescence resonance energy transfer. , 2010, Cancer research.

[74]  P. Brooks,et al.  Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin. , 2007, Cancer research.

[75]  S. Weiss,et al.  MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing , 2009, Journal of Cell Science.

[76]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[77]  S. Formenti,et al.  Disruption of Endothelial Cell Interactions with the Novel HU177 Cryptic Collagen Epitope Inhibits Angiogenesis , 2007, Clinical Cancer Research.

[78]  R. Kalluri Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[79]  S. Groshen,et al.  Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment , 2004, Cancer Research.

[80]  Richard Mayne,et al.  Multiple Binding Sites in Collagen Type I for the Integrins α1β1 and α2β1 * , 2000, The Journal of Biological Chemistry.

[81]  D. Gingras,et al.  Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. , 2004, Blood.

[82]  Sarah L Dallas,et al.  Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. , 2002, The Journal of biological chemistry.

[83]  M. Detmar,et al.  The α1β1 and α2β1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis , 2002 .

[84]  S. Germain,et al.  Critical overexpression of thrombospondin 1 in chronic leg ischaemia , 2005, The Journal of pathology.

[85]  C. López-Otín,et al.  Membrane type-matrix metalloproteinases (MT-MMP). , 2003, Current topics in developmental biology.

[86]  P. Quax,et al.  Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. , 2003, Blood.

[87]  R. Iozzo Basement membrane proteoglycans: from cellar to ceiling , 2005, Nature Reviews Molecular Cell Biology.

[88]  A. Turner,et al.  MT1-MMP association with membrane lipid rafts facilitates G-CSF--induced hematopoietic stem/progenitor cell mobilization. , 2010, Experimental hematology.

[89]  I. Jo,et al.  Coordinated regulation of angiopoietin-1 and vascular endothelial growth factor by arsenite in human brain microvascular pericytes: implications of arsenite-induced vascular dysfunction. , 2009, Toxicology.

[90]  A. Strongin,et al.  Timp‐2 binding with cellular MT1‐MMP stimulates invasion‐promoting MEK/ERK signaling in cancer cells , 2009, International journal of cancer.

[91]  D. Hanahan,et al.  Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. , 2006, Genes & development.

[92]  S. Dangi‐Garimella,et al.  Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression , 2011, Oncogene.

[93]  D. McDonald,et al.  Cellular abnormalities of blood vessels as targets in cancer. , 2005, Current opinion in genetics & development.

[94]  A. Nagler,et al.  MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. , 2009, The Journal of clinical investigation.

[95]  L. Orci,et al.  Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids , 1983, The Journal of cell biology.

[96]  A. Verkman,et al.  Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[97]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[98]  A. A. Miles,et al.  Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigs , 1952, The Journal of physiology.

[99]  S. Belmadani,et al.  Involvement of Metalloproteinases 2/9 in Epidermal Growth Factor Receptor Transactivation in Pressure-Induced Myogenic Tone in Mouse Mesenteric Resistance Arteries , 2004, Circulation.

[100]  Y. Takeishi,et al.  Involvement of membrane type 1‐matrix metalloproteinase (MT1‐MMP) in RAGE activation signaling pathways , 2011, Journal of cellular physiology.

[101]  M. Bernardo,et al.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer , 2008, Cancer and Metastasis Reviews.

[102]  J. Keski‐Oja,et al.  MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. , 2008, Experimental cell research.

[103]  B. Lévy,et al.  Regulation of Matrix Metalloproteinase Activity in Ischemic Tissue by Interleukin-10: Role in Ischemia-Induced Angiogenesis , 2001, Circulation research.

[104]  T. Fujii,et al.  An Autocrine Linkage Between Matrix Metalloproteinase-14 and Tie-2 Via Ectodomain Shedding Modulates Angiopoietin-1–Dependent Function in Endothelial Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[105]  R. Jaenisch,et al.  A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling , 1995, The Journal of cell biology.

[106]  S. Weiss,et al.  Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent Processes , 2002, The Journal of experimental medicine.

[107]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[108]  R. Rich,et al.  Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. , 2000, The Journal of biological chemistry.

[109]  C. Overall,et al.  Characterization of the Distinct Collagen Binding, Helicase and Cleavage Mechanisms of Matrix Metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP) , 2004, Journal of Biological Chemistry.

[110]  H. Munshi,et al.  Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. , 2006, Cancer research.

[111]  L. Devy,et al.  MT1‐MMP expression promotes tumor growth and angiogenesis through an up‐regulation of vascular endothelial growth factor expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[112]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[113]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[114]  A. Strongin,et al.  Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. , 2002, Cancer research.

[115]  E. Im,et al.  Phospholipase Cγ Activation Drives Increased Production of Autotaxin in Endothelial Cells and Lysophosphatidic Acid-Dependent Regression , 2010, Molecular and Cellular Biology.

[116]  Stephen J. Weiss,et al.  MT1-MMP–dependent neovessel formation within the confines of the three-dimensional extracellular matrix , 2004, The Journal of cell biology.

[117]  S. Dangi‐Garimella,et al.  Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion* , 2011, The Journal of Biological Chemistry.

[118]  M. Ratajczak,et al.  Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells. , 2011, Stem cells and development.

[119]  E. Im,et al.  New Insights Regarding Vessel Regression , 2006, Cell Cycle.

[120]  H. Kleinman,et al.  Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting , 1999 .

[121]  H. Verspaget,et al.  Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. , 2010, Cancer research.

[122]  N. Boudreau,et al.  Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.

[123]  M. Hendrix,et al.  Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.

[124]  I. Stamenkovic,et al.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.

[125]  H. Kleinman,et al.  Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. , 2003, Experimental cell research.

[126]  C. López-Otín,et al.  Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.

[127]  Y. Itoh,et al.  Matrix metalloproteinases in cancer. , 2002, Essays in biochemistry.

[128]  M. Klagsbrun,et al.  Matrix Metalloproteinase-3 Releases Active Heparin-binding EGF-like Growth Factor by Cleavage at a Specific Juxtamembrane Site* , 1997, The Journal of Biological Chemistry.

[129]  J. Foidart,et al.  Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture , 2009, Journal of cellular and molecular medicine.

[130]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[131]  S. Weiss,et al.  An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature. , 2005, Genes & development.

[132]  I. Weissman,et al.  Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth , 2008, Proceedings of the National Academy of Sciences.

[133]  Y. Okada,et al.  Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. , 1997, The Biochemical journal.

[134]  Y. Okada,et al.  Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.